Drugs Made In America Acquisition Corp (DMAA:NASDAQ)

$10.46 0.00 (0.00%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 64

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Drugs Made In America Acquisition Corp (DMAA:NASDAQ) News Sources

Gilead Sciences Is Acquiring Arcellx and Partnered Multiple Myeloma Drug in $7.8B Deal

Dealbreaker on MSN

external link

Aspire Biopharma’s Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship

USA TODAY

external link

What experts say about Hims & Hers’ $1.15B acquisition of Eucalyptus

Dealbreaker on MSN

external link

McKesson Corporation: Strong Q3 Earnings But Upside Exhausted

Seeking Alpha

external link

Eris Lifesciences inks deal with Natco Pharma for weight-loss drug semaglutide

Mint on MSN

external link

Global PE firms line up for IndiaRF’s Synthimed Labs in $150-200 million deal

Mint

external link

Dr. Reddy’s Laboratories shares in focus after acquiring India trademarks for two HRT drugs for $32 million

The Economic Times on MSN

external link

SureNano Science Ltd. Acquires GlucaPharm Inc., Advancing Second-Generation FDA Pathway GLP-1 Drug Development

Cantech Letter

external link

Cream Cheese Recall; Nobel Winner Resigns Over Epstein Ties; Cadaver Fat in Surgery

MedPage Today

external link

Eucalyptus sells to New York-listed healthcare giant in $1.6b deal

Australian Financial Review

external link
DMAA stock
DMAA stock price
DMAA stock price today
DMAA stock prediction
DMAA earnings date
DMAA news
DMAA price
DMAA share
DMAA share price
DMAA shares
DMAA ceo
DMAA premarket
$DMAA
DMAA ticker
DMAA after hours
DMAA stock
DMAA stock price
DMAA stock price today
DMAA stock prediction
DMAA earnings date
DMAA news
DMAA price
DMAA share
DMAA share price
DMAA shares
DMAA ceo
DMAA premarket
$DMAA
DMAA ticker
DMAA after hours

Drugs Made In America Acquisition Corp (DMAA:NASDAQ) FAQs

toggle

What is the current price of Drugs Made In America Acquisition Corp (DMAA:NASDAQ)?

The current price of Drugs Made In America Acquisition Corp (DMAA:NASDAQ) is $10.46.


toggle

Drugs Made In America Acquisition Corp (DMAA:NASDAQ) absolute price change since previous trading day?

The absolute price change of Drugs Made In America Acquisition Corp (DMAA:NASDAQ) since the previous trading day is $0.00.


toggle

Drugs Made In America Acquisition Corp (DMAA:NASDAQ) percentage price change since previous trading day?

The percentage price change of Drugs Made In America Acquisition Corp (DMAA:NASDAQ) since the previous trading day is 0.00%.


toggle

What is This Week's average sentiment score for Drugs Made In America Acquisition Corp (DMAA:NASDAQ)?

This Week's average sentiment score for Drugs Made In America Acquisition Corp (DMAA:NASDAQ) is 64 out of 100.


toggle

What is This Week's average sentiment for Drugs Made In America Acquisition Corp (DMAA:NASDAQ)?

This Week's sentiment for Drugs Made In America Acquisition Corp (DMAA:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.